News About: Pharm. Industry
Pfizer Korea wins Lyrica patent suit
The Korean Intellectual Property Tribunal has ruled in favor of Pfizer Korea in a patent nullification suit involving Pfizer’s use patent covering Lyrica (pregabalin).
Lyrica is used to treat chronic pain disorders...
CJ to appeal against to Lyrica ruling
CJ Pharm said Wednesday that it will appeal against the latest ruling by Korean Intellectual Property Tribunal that favored Pfizer Korea over the nullification trial of Pfizer’s use patent covering Lyrica (pregabalin)...
Domestic firms’ strategic alliances with multinational firms up
A number of domestic pharmaceutical companies have already established strategic alliances with multinational drug manufacturers for co-marketing and/or co-development of new drugs to effectively minimize outlays for ...
Court dismisses Dong-A’s collusion over Valtrex
The Seoul Higher Court ruled Wednesday that Dong-A Pharm did not collude with GlaxoSmithKline (GSK) over the sales of GSK’s Valtrex (valaciclovir).
Therefore, the court said that the fines imposed by the Fair Trade...
Chairman Kim become largest shareholder at Handok
Handok Pharm Wednesday said in its regulatory filing that incumbent chairman Kim Young-jin is the largest shareholder as the company acquired a 50 percent stake from Hoechst.
The acquisition aims at protecting the ...
BMS Korea’s labor dispute is still going on
BMS and unionists are still on a collision course as no headway has been reached on a wage deal with management since June
"Workers are always angry at the decision by the company to raise their annual wages while ...
Korea emerging as global drug trial hub
Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical companies thanks to its excellent infrastructure for clinical research.
The appeal is the country’s highly qualified med...
SK Chemicals’ largest GMP plant completed
SK Chemicals Co. has completed its largest GMP plant in Chungju, North Chungcheong Province as part of its efforts to expand the annual production of solid forms and patch.
A completion ceremony was held Tuesday, 1...
New prescription plan is burdensome to drug makers
In a 2013 medical service fee negotiation with the National Health Insurance Corporation, the Korean Medical Association opposed new prescription plan, under which doctors will be required to prescribe the actual chem...
Ildong announces combination product license agreement with Ajinomoto
Ildong Pharm last Thursday announced that it has entered into a commercial license agreement with Ajinomoto Pharmaceutical Co. to market a combination drug containing cilnidipine and valsartan in Korea.
Ildong is e...
